CA2879324A1 - Method and system to indicate hyperglycemia or hypoglycemia for people with diabetes - Google Patents

Method and system to indicate hyperglycemia or hypoglycemia for people with diabetes Download PDF

Info

Publication number
CA2879324A1
CA2879324A1 CA2879324A CA2879324A CA2879324A1 CA 2879324 A1 CA2879324 A1 CA 2879324A1 CA 2879324 A CA2879324 A CA 2879324A CA 2879324 A CA2879324 A CA 2879324A CA 2879324 A1 CA2879324 A1 CA 2879324A1
Authority
CA
Canada
Prior art keywords
blood glucose
glucose measurements
insulin
threshold
hypoglycemic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2879324A
Other languages
English (en)
French (fr)
Inventor
Frances Wilson HOWELL
Janice MACLEOD
David Rodbard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LifeScan Inc
Original Assignee
LifeScan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LifeScan Inc filed Critical LifeScan Inc
Publication of CA2879324A1 publication Critical patent/CA2879324A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M2005/14208—Pressure infusion, e.g. using pumps with a programmable infusion control system, characterised by the infusion program
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3546—Range
    • A61M2205/3553—Range remote, e.g. between patient's home and doctor's office
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3546—Range
    • A61M2205/3569—Range sublocal, e.g. between console and disposable
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
    • A61M2205/3584—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using modem, internet or Bluetooth®
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
    • A61M2205/3592—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using telemetric means, e.g. radio or optical transmission

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medical Informatics (AREA)
  • Veterinary Medicine (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Surgery (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Optics & Photonics (AREA)
  • Emergency Medicine (AREA)
  • General Business, Economics & Management (AREA)
  • Business, Economics & Management (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • External Artificial Organs (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
CA2879324A 2012-07-19 2013-07-18 Method and system to indicate hyperglycemia or hypoglycemia for people with diabetes Abandoned CA2879324A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13/553,655 US20140024907A1 (en) 2012-07-19 2012-07-19 Method and system to indicate hyperglycemia or hypoglycemia for people with diabetes
US13/553,655 2012-07-19
PCT/US2013/051113 WO2014015160A2 (en) 2012-07-19 2013-07-18 Method and system to indicate hyperglycemia or hypoglycemia for people with diabetes

Publications (1)

Publication Number Publication Date
CA2879324A1 true CA2879324A1 (en) 2014-01-23

Family

ID=49947119

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2879324A Abandoned CA2879324A1 (en) 2012-07-19 2013-07-18 Method and system to indicate hyperglycemia or hypoglycemia for people with diabetes

Country Status (13)

Country Link
US (1) US20140024907A1 (enExample)
EP (1) EP2874541A4 (enExample)
JP (1) JP2015530889A (enExample)
KR (1) KR20150036706A (enExample)
CN (1) CN104470430A (enExample)
AU (1) AU2013292522A1 (enExample)
BR (1) BR112015001038A2 (enExample)
CA (1) CA2879324A1 (enExample)
HK (1) HK1209996A1 (enExample)
IN (1) IN2015DN00397A (enExample)
RU (1) RU2015105626A (enExample)
TW (1) TW201417774A (enExample)
WO (1) WO2014015160A2 (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014036177A1 (en) * 2012-08-30 2014-03-06 Abbott Diabetes Care Inc. Optimizing medication dosage based on analyte sensor data
US9486580B2 (en) 2014-01-31 2016-11-08 Aseko, Inc. Insulin management
US9898585B2 (en) 2014-01-31 2018-02-20 Aseko, Inc. Method and system for insulin management
US11081226B2 (en) 2014-10-27 2021-08-03 Aseko, Inc. Method and controller for administering recommended insulin dosages to a patient
JP6989262B2 (ja) 2014-10-27 2022-01-05 アセコー インコーポレイテッド 皮下外来患者管理
CA2991716C (en) * 2015-07-10 2026-05-12 Abbott Diabetes Care Inc. System, device and method of dynamic glucose profile response to physiological parameters
EP3337402B1 (en) 2015-08-20 2026-01-07 Glytec, LLC Diabetes management therapy advisor
FR3047098B1 (fr) * 2016-01-21 2018-05-25 Voluntis Gestion de l'equilibre glycemique d'un patient diabetique
EP4303884A3 (en) 2016-01-29 2024-04-03 University of Virginia Patent Foundation d/b/a University of Virginia Licensing & Ventures Group Method, system, and computer readable medium for virtualization of a continuous glucose monitoring trace
CN108283486B (zh) * 2017-01-09 2021-04-09 腾讯科技（深圳）有限公司 测量数据的处理方法及装置
TWI668664B (zh) * 2017-01-16 2019-08-11 華廣生技股份有限公司 Method for dynamically analyzing blood sugar level, system thereof and computer program product
CN108335750B (zh) * 2017-01-20 2022-08-09 华广生技股份有限公司 动态分析血糖值的方法、系统与计算机存储介质
EP3361402B1 (en) * 2017-02-14 2024-12-04 Roche Diabetes Care GmbH A computer-implemented method and a portable device for analyzing glucose monitoring data indicative of a glucose level in a bodily fluid, and a non-transitory computer readable medium
EP3600014B1 (en) * 2017-03-21 2025-07-30 Abbott Diabetes Care Inc. Devices and system for providing diabetic condition diagnosis
USD853583S1 (en) 2017-03-29 2019-07-09 Becton, Dickinson And Company Hand-held device housing
TWI678630B (zh) * 2018-01-16 2019-12-01 中央研究院 非侵入式估測hba1c與血糖值之系統與方法
JP7471302B2 (ja) 2018-12-19 2024-04-19 サノフイ 血糖測定値のパターン認識エンジン
JP7657428B2 (ja) 2019-07-16 2025-04-07 ベータ バイオニクス，インコーポレイテッド 血糖制御システム
EP3839963B1 (en) * 2019-12-20 2026-04-15 Digital Diabetes Analytics Sweden AB Diabetes analysis system, and method in relation to the system
WO2022126080A1 (en) 2020-12-07 2022-06-16 Beta Bionics, Inc. Medicament pumps and control systems for managing glucose control therapy data of a subject
USD1032623S1 (en) 2020-03-10 2024-06-25 Beta Bionics, Inc. Display screen with animated graphical user interface
US11278661B2 (en) 2020-03-10 2022-03-22 Beta Bionics, Inc. Infusion system and components thereof
USD1032624S1 (en) 2020-03-10 2024-06-25 Beta Bionics, Inc. Display screen with animated graphical user interface
CN111653337A (zh) * 2020-05-19 2020-09-11 曲靖师范学院 一种血糖设备控制方法、系统、装置、存储介质、程序
US20220199218A1 (en) 2020-12-07 2022-06-23 Beta Bionics, Inc. Ambulatory medicament pump with integrated medicament ordering interface
EP4262924A4 (en) * 2020-12-21 2024-11-20 Beta Bionics, Inc. Medicament pumps and control systems thereof
US11497852B2 (en) * 2020-12-21 2022-11-15 Beta Bionics, Inc. Ambulatory medicament device with power saving mode
USD1127405S1 (en) 2021-03-25 2026-05-26 Beta Bionics, Inc. Clip for bionic pancreas infusion pump cases
US12465686B2 (en) 2021-03-25 2025-11-11 Beta Bionics, Inc. Emergency medicament dose control
WO2026054488A1 (ko) * 2024-09-04 2026-03-12 사회복지법인 삼성생명공익재단 연속혈당측정기를 이용하여 당뇨병 환자를 관리하는 방법, 장치 및 컴퓨터 프로그램

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4891511B2 (ja) * 2000-03-29 2012-03-07 ユニバーシテイ・オブ・バージニア・パテント・フアウンデーシヨン 自己モニタリングデータから糖尿病の血糖管理を評価する方法、システム及びコンピユータプログラム製品
US7824333B2 (en) * 2006-03-31 2010-11-02 Lifescan, Inc. Diabetes management methods and systems
US8758245B2 (en) * 2007-03-20 2014-06-24 Lifescan, Inc. Systems and methods for pattern recognition in diabetes management
US20090240127A1 (en) * 2008-03-20 2009-09-24 Lifescan, Inc. Methods of determining pre or post meal time slots or intervals in diabetes management
EP2354990A1 (en) * 2010-02-03 2011-08-10 Clifton A. Alferness System and method for actively managing type 1 diabetes mellitus on a personalized basis
US8206340B2 (en) * 2010-08-18 2012-06-26 Thuban, Inc. Integrated glucose monitor and insulin injection pen with automatic emergency notification

Also Published As

Publication number Publication date
WO2014015160A2 (en) 2014-01-23
BR112015001038A2 (pt) 2017-06-27
AU2013292522A1 (en) 2015-03-05
US20140024907A1 (en) 2014-01-23
HK1209996A1 (en) 2016-04-15
EP2874541A2 (en) 2015-05-27
TW201417774A (zh) 2014-05-16
WO2014015160A3 (en) 2015-04-30
KR20150036706A (ko) 2015-04-07
IN2015DN00397A (enExample) 2015-06-19
RU2015105626A (ru) 2016-09-10
EP2874541A4 (en) 2016-06-08
CN104470430A (zh) 2015-03-25
JP2015530889A (ja) 2015-10-29

Similar Documents

Publication Publication Date Title
US20140024907A1 (en) Method and system to indicate hyperglycemia or hypoglycemia for people with diabetes
US9402956B2 (en) Handheld diabetes manager with a user interface for displaying a status of an external medical device
US20140074059A1 (en) Method and system to indicate glycemic impacts of insulin infusion pump commands
KR101722417B1 (ko) 고혈당 및 저혈당 경향 통지를 갖는 분석물 검사 방법 및 시스템
EP2654564B1 (en) Calibration of a handheld diabetes managing device that receives data from a continuous glucose monitor
US9504412B2 (en) Method and system to derive glycemic patterns from clustering of glucose data
US9592002B2 (en) Method and system to derive multiple glycemic patterns from glucose measurements during time of the day
US20120165639A1 (en) Storage of calibration data at a continuous glucose monitor
CA2766870A1 (en) Systems for diabetes management and methods
US20140128837A1 (en) Systems and methods for managing glycemic variability
US20140172449A1 (en) Metadata tagging system for a diabetes management system of devices
AU2013235546A1 (en) Positive reinforcement messages to users based on analytics of prior physiological measurements
HK1188311B (en) Updatability of structured blood glucose tests on handheld diabetes management devices
HK1188311A (en) Updatability of structured blood glucose tests on handheld diabetes management devices

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20190718